190 related articles for article (PubMed ID: 19236823)
1. Natriuretic peptides in the management of aortic stenosis.
Bergler-Klein J
Curr Cardiol Rep; 2009 Mar; 11(2):85-93. PubMed ID: 19236823
[TBL] [Abstract][Full Text] [Related]
2. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
[TBL] [Abstract][Full Text] [Related]
3. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of NT-proBNP and an adapted monin score in patients with asymptomatic aortic stenosis.
Farré N; Gómez M; Molina L; Cladellas M; Blé M; Roqueta C; Ascoeta MS; Comin-Colet J; Vila J; Bruguera J
Rev Esp Cardiol (Engl Ed); 2014 Jan; 67(1):52-7. PubMed ID: 24774264
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Prognostic Value of High-Sensitivity Troponin T Added to N-Terminal Pro Brain Natriuretic Peptide Plasma Levels Before Valve Replacement for Severe Aortic Stenosis.
Barbieri F; Senoner T; Adukauskaite A; Dobner S; Holfeld J; Semsroth S; Lambert T; Zweiker D; Theurl T; Rainer PP; Schmidt A; Feuchtner GM; Steinwender C; Hoppe UC; Hintringer F; Bauer A; Müller S; Grimm M; Pfeifer BE; Dichtl W
Am J Cardiol; 2019 Dec; 124(12):1932-1939. PubMed ID: 31699359
[TBL] [Abstract][Full Text] [Related]
6. [Role of natriuretic peptides in the assessment of aortic stenosis severity].
Davicević Z; Tavciovski D; Matunović R; Vukotić S; Mijailović Z
Vojnosanit Pregl; 2010 Aug; 67(8):622-6. PubMed ID: 20845663
[TBL] [Abstract][Full Text] [Related]
7. Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation.
Koskinas KC; O'Sullivan CJ; Heg D; Praz F; Stortecky S; Pilgrim T; Buellesfeld L; Jüni P; Windecker S; Wenaweser P
Am J Cardiol; 2015 Nov; 116(10):1560-5. PubMed ID: 26428025
[TBL] [Abstract][Full Text] [Related]
8. Relationship between prosthesis-patient mismatch and pro-brain natriuretic peptides after aortic valve replacement.
Melina G; Angeloni E; Benedetto U; Refice S; Miceli A; Miele C; Ciavarella GM; Sinatra R
J Heart Valve Dis; 2010 Mar; 19(2):171-6. PubMed ID: 20369499
[TBL] [Abstract][Full Text] [Related]
9. Effect of the 2017 European Guidelines on Reclassification of Severe Aortic Stenosis and Its Influence on Management Decisions for Initially Asymptomatic Aortic Stenosis.
Chan DCS; Singh A; Greenwood JP; Dawson DK; Lang CC; Berry C; Pakkal M; Everett RJ; Dweck MR; Ng LL; McCann GP
Circ Cardiovasc Imaging; 2020 Dec; 13(12):e011763. PubMed ID: 33287584
[TBL] [Abstract][Full Text] [Related]
10. Natriuretic peptides and long-term mortality in patients with severe aortic stenosis.
Katz M; Tarasoutchi F; Pesaro AE; Lopes RD; Spina GS; Vieira ML; Grinberg M
J Heart Valve Dis; 2012 May; 21(3):331-6. PubMed ID: 22808834
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis.
Bergler-Klein J; Klaar U; Heger M; Rosenhek R; Mundigler G; Gabriel H; Binder T; Pacher R; Maurer G; Baumgartner H
Circulation; 2004 May; 109(19):2302-8. PubMed ID: 15117847
[TBL] [Abstract][Full Text] [Related]
12. [Biomarkers for the evaluation of valvular aortic stenosis].
Weber M; Hamm C
Herz; 2006 Oct; 31(7):658-63. PubMed ID: 17072779
[TBL] [Abstract][Full Text] [Related]
13. Synergistic Utility of Brain Natriuretic Peptide and Left Ventricular Strain in Patients With Significant Aortic Stenosis.
Goodman A; Kusunose K; Popovic ZB; Parikh R; Barr T; Sabik JF; Rodriguez LL; Svensson LG; Griffin BP; Desai MY
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26732551
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of B-type natriuretic peptide in elderly patients with aortic valve stenosis: the COFRASA-GENERAC study.
Cimadevilla C; Cueff C; Hekimian G; Dehoux M; Lepage L; Iung B; Duval X; Huart V; Tubach F; Vahanian A; Messika-Zeitoun D
Heart; 2013 Apr; 99(7):461-7. PubMed ID: 23349346
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of N-Terminal Pro-form B-Type Natriuretic Peptide in Patients With Moderate Aortic Stenosis.
Ito S; Miranda WR; Jaffe AS; Oh JK
Am J Cardiol; 2020 May; 125(10):1566-1570. PubMed ID: 32204871
[TBL] [Abstract][Full Text] [Related]
17. Impact of N-terminal pro-B-type natriuretic peptide response on long-term prognosis after transcatheter aortic valve implantation for severe aortic stenosis and heart failure.
Kaneko H; Hoelschermann F; Tambor G; Okamoto M; Neuss M; Butter C
Heart Vessels; 2019 May; 34(5):777-783. PubMed ID: 30443765
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of N-terminal pro-B-type natriuretic peptide in patients with normal left ventricular ejection fraction undergoing transcatheter aortic valve implantation.
Seoudy H; Kuhn C; Frank J; Eden M; Rangrez AY; Lutter G; Frey N; Frank D
Int J Cardiol; 2020 Feb; 301():195-199. PubMed ID: 31757644
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of B-type natriuretic peptide and N-terminal pro--B-type natriuretic peptide in the care of the vascular surgery patient.
Wayne Causey M; Singh N
Semin Vasc Surg; 2014 Dec; 27(3-4):143-7. PubMed ID: 26073822
[TBL] [Abstract][Full Text] [Related]
20. B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin for Risk Stratification in Low-Flow, Low-Gradient Aortic Stenosis: A Substudy of the TOPAS Study.
Dahou A; Clavel MA; Capoulade R; O'Connor K; Ribeiro HB; Côté N; Le Ven F; Rodés-Cabau J; Dumesnil JG; Mathieu P; Pibarot P
JACC Cardiovasc Imaging; 2018 Jul; 11(7):939-947. PubMed ID: 28917673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]